Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Director Sells $194,174.30 in Stock

Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Free Report) Director Deepika Pakianathan sold 204,394 shares of the business’s stock in a transaction dated Friday, May 31st. The shares were sold at an average price of $0.95, for a total value of $194,174.30. Following the sale, the director now owns 14,697 shares in the company, valued at […]

Leave a Reply

Your email address will not be published.

Previous post Insider Buying: Discovery Silver Corp. (CVE:DSV) Senior Officer Purchases C$119,356.00 in Stock
Next post BNP Paribas Begins Coverage on First Industrial Realty Trust (NYSE:FR)